Sutinat (Sunitinib)
In stock
Description
Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase inhibitor for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor.
Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase inhibitor for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor.